[INQ. NO. 1705C35] Red ginseng has proved its pharmacological benefits for thousands of years, and saponin ginsenoside is its key ingredient. However, the amount of saponin contained in the red ginseng products currently distributed on the market is not more than 4.5 mg/g to 12 mg/g.
ARBEGO red ginseng produced by CULDUCT R&D through “Saponin Extract from Red Ginseng and Method for Manufacturing the Same” (Korean Patent Application No. 10-1505881) has a saponin content of Rg1 + Rb1 + Rg3 = 33 mg/g which is much higher than that of existing red ginseng products. In particular, it contains 57.3mg/g of saponin ginsenoside, which is 10.36 times higher than that of Korea Ginseng Corp (KGC), the biggest ginseng producer in Korea, containing 5.5mg/g. Developed as a part of the Korean Small Business Innovation Research Program (KOSBIR), ARBEGO has registered patents in Korea and Japan, and has patents pending in China and the USA for its global expansion.
Based on maximized saponin content, CULDUCT R&D has overcome limitations of the application by paving the way to use red ginseng in the medical field, expanding its compatibility to cosmetics and further as foods.
Korean-Products.com | Blog Magazine of Korean products, brands and Goods